Cairo- Mubasher: The Egyptian International Pharmaceutical Industries Company (EIPICO) posted a year-on-year increase in its unconsolidated profits during the first half of 2019, based on the initial unaudited statements of the company.
EIPICO logged EGP 371.2 million in H1-19, compared to EGP 368.5 million in H1-18, including minority shareholders’ rights, EIPICO disclosed to the Egyptian Exchange (EGX) on Wednesday.
Sales hiked to EGP 1.6 billion in H1-19 from EGP 1.3 billion in H1-18.
It is worth noting that during the first quarter of 2019, the company’s net profits surged to EGP 218.31 from EGP 183.97 million in Q1-18.
Source: Mubasher
All Rights Reserved - Mubasher Info © 2005 - 2019 Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
